Literature DB >> 6270170

Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor.

S A Leveston, D W McKeel, P J Buckley, K Deschryver, M H Greider, B M Jaffe, W H Daughaday.   

Abstract

We report an 18-yr-old youth with a metastatic foregut carcinoid tumor, Cushing's syndrome, and hypersomatotropic gigantism. Administration of cyproheptadine caused a dramatic fall in urinary cortisol excretion and plasma ACTH levels associated with clinical remission of the Cushing's syndrome. GH secretion was not affected by cyproheptadine administration. Ectopic ACTH secretion was confirmed by RIA of tumor extracts and immunohistochemical demonstration of ACTH-containing cells in hepatic metastases. There were two sources of GH production demonstrated in this patient. Ectopic secretion of GH by the carcinoid hepatic metastases was documented by both RIA and immunohistochemical techniques. A somatotrophic pituitary tumor was also present. The histological characteristics of this tumor suggest adenomatous hyperplasia rather than de novo neoplastic change as the likely mechanism of its pathogenesis. GH releasing factor-like activity was demonstrated in extracts of plasma and in extracts of the carcinoid tumor. We conclude that cyproheptadine exerted an effect on the ectopic ACTH-producing cells but not on the ectopic GH-producing cells or on adenohypophyseal GH secretion. Production of a GH releasing factor-like activity by the carcinoid tumor may have caused the pituitary somatotrophic tumor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270170     DOI: 10.1210/jcem-53-4-682

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Coexisting acromegaly and a unilateral cortisol-producing adrenal adenoma: a possible variant of multiple endocrine neoplasia type I.

Authors:  H Watanobe; K Kudo; T Okushima; M Nakazono; M Kudo; K Takebe
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.

Authors:  M B Lopes; B D Gaylinn; M O Thorner; M H Stoler
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Intrasellar hamartoma associated with pituitary adenoma.

Authors:  F Slowik; I Fazekas; K Bálint; L Gazsó; E Pásztor; S Czirják; K Lapis
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 4.  Ectopic secretion of growth hormone-releasing hormone in man.

Authors:  M Losa; J Schopohl; K von Werder
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

5.  Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.

Authors:  J A Goldman; M E Molitch; M O Thorner; W Vale; J Rivier; S Reichlin
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

6.  Acromegaly and thymic hyperplasia: a case report.

Authors:  N Bazzoni; B Ambrosi; M Arosio; M Barbareschi; M Losa; G Faglia
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

7.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Authors:  M O Thorner; R L Perryman; M J Cronin; A D Rogol; M Draznin; A Johanson; W Vale; E Horvath; K Kovacs
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

Review 8.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

Review 9.  Current management of gastrointestinal carcinoid tumors.

Authors:  Kenneth J Woodside; Courtney M Townsend; B Mark Evers
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.452

10.  Growth-hormone-releasing factor immunoreactivity in human endocrine tumors.

Authors:  D G Bostwick; R Quan; A R Hoffman; R J Webber; J K Chang; K G Bensch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.